Xeris Biopharma Holdings, Inc. (XERS) Free Cash Flow
Xeris Biopharma Holdings, Inc. (XERS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | -$96.62M |
| 2022-12-31 | -$103.42M |
| 2023-03-31 | -$26.38M |
| 2023-06-30 | -$41.67M |
| 2023-12-31 | -$47.02M |
| 2024-12-31 | -$36.98M |
| 2025-12-31 | $28.63M |
How XERS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AZTA | Azenta Inc. | $38.32M |
| INNV | InnovAge Holding Corp. | $26.60M |
| VCEL | Vericel Corporation | $24.75M |
| NRC | National Research Corporation | $15.74M |
| ETON | Eton Pharmaceuticals Inc. | $10.19M |
These are five companies in the same sector as XERS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("XERS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XERS | $8.43 | -0.12% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 |